Back to Studies

IMPAACT 2040

Pharmacokinetics and Safety of Long-Acting Injectable Cabotegravir and Rilpivirine in Virally Suppressed People with HIV-1 during Pregnancy and Postpartum

Overview
Protocol Team

Study Status

In Development

IND Number

TBD

Clinical Trials Link

TBD

Primary Protocol Team Members

Rachel Scott Study Chair

Adrie Bekker Study Vice-Chair

Ellen Townley DAIDS Medical Officer

Renee Browning DAIDS Medical Officer

Jack Moye Jr. NICHD Medical Officer

Sonia Lee NICHD Medical Officer

Loading study documents...

Loading study sites...

Loading study protocol team...

Loading study press...

Loading study publications/presentations...